Přejít k hlavnímu obsahu
Header image

Dömling Alexander PhD.

Journals

BARAKAT, A., S. ALSHAHRANI, A. AL-MAJID, A. ALAMARY, M. HAUKKA, M. ABU-SERIE, A. DÖMLING, L. DOMINGO, Y. ELSHAIER
Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules. Frontiers in Pharmacology. 2024, 15, 1358089, ISSN: 1663-9812, PMID: 38650632,  PDF.
LI, Y., Q. ZHENG, A. DÖMLING
Exploring Phthalimide as the Acid Component in the Passerini Reaction. Organic Letters. 2024, 26(4), 829-833, ISSN: 1523-7060, PMID: 38227542,
CHATZIORFANOU, E., A. REYES ROMERO, L. CHOUCHANE, A. DÖMLING
Crystal Clear: Decoding Isocyanide Intermolecular Interactions through Crystallography. The Journal of Organic Chemistry. 2024, 89(2), 957-974, ISSN: 0022-3263, PMID: 38175810.

Doctoral mentorship

Guan Zhirui

Discovery and development of novel macrocycles via Multicomponent reactions

Stav: Probíhající od 2023.
Capriello Imma

Molecular targets for innovative pharmaceutics

Stav: Probíhající od 2023.
Fusco Riccardo

Plasmonic Nanomaterials in Cancer Theranostics

Stav: Probíhající od 2023.

Open positions

Projekt: New anti-inflammatory small molecules
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Microsynthesis of drug candidates in medicinal chemistry
Vedoucí: Dömling Alexander PhD.
K dispozici: 2
Určeno pro: Doktorské studium
Souhrn: 2 places in full-time study
Projekt: Innovative approaches to modifiers of protein interactions
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Utilization of the space of unprecedented covalent inhibitors
Vedoucí: Dömling Alexander PhD., Džubák Petr M.D., Ph.D.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Discovery of new antibacterial substances
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Discovery of new antitumor substances
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Innovative drugs for Parkinson's disease
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Innovative medicinal chemistry
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Decoding the binding principles of small molecules to RNA
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Targeted approaches to covalent inhibitors
Vedoucí: Dömling Alexander PhD., Džubák Petr M.D., Ph.D.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Synthesis of kinase inhibitors and their phenotypic chemoproteomic evaluation
Vedoucí: Dömling Alexander PhD., Džubák Petr M.D., Ph.D.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Modification of biologically active molecules leading to their improvement pharmacological properties
Vedoucí: Dömling Alexander PhD.
K dispozici: 2
Určeno pro: Doktorské studium
Souhrn: 2 places in full-time study
Projekt: New methods of targeted protein degradation
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Drug repurposing for the treatment and prevention of diseases
Vedoucí: Hajdúch Marián M.D., Ph.D., Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: New chemoinformatic approaches to fragment-based drug discovery
Vedoucí: Dömling Alexander PhD.
K dispozici: 1
Určeno pro: Doktorské studium
Souhrn: 1 place in full-time study
Projekt: Development of drugs in the field of small molecules 2 places in full-time study
Vedoucí: Dömling Alexander PhD., Hajdúch Marián M.D., Ph.D.
K dispozici: 2
Určeno pro: Doktorské studium
Souhrn: 2 places in full-time study